The effects of denosumab on calcium profiles in advanced cancer patients with bone metastases

被引：0
|
作者：
Breanne Lechner
Carlo DeAngelis
Noreen Jamal
Urban Emmenegger
Natalie Pulenzas
Angie Giotis
Parker Sheehan
May Tsao
Gillian Bedard
Edward Chow
机构：
[1] University of Toronto,Rapid Response Radiotherapy Program, Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre
[2] University of Toronto,Department of Pharmacy, Odette Cancer Centre, Sunnybrook Health Sciences Centre
[3] University of Toronto,Department of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre
来源：
Supportive Care in Cancer | 2014年 / 22卷
关键词：
Denosumab; Hypocalcemia; Bone metastases;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1765 / 1771
页数：6
相关论文
共 50 条
  • [21] Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents
    Patrick, Donald L.
    Cleeland, Charles S.
    von Moos, Roger
    Fallowfield, Lesley
    Wei, Rachel
    Oehrling, Katarina
    Qian, Yi
    SUPPORTIVE CARE IN CANCER, 2015, 23 (04) : 1157 - 1168
  • [22] Impact of denosumab on bone mass in cancer patients
    Brown-Glaberman, Ursa
    Stopeck, Alison T.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2013, 5 : 117 - 129
  • [23] Use and safety of denosumab in cancer patients
    Manzaneque, Alba
    Chaguaceda, Cristian
    Mensa, Mireia
    Bastida, Carla
    Creus-Baro, Natalia
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (03) : 522 - 526
  • [24] Quantitative Pharmacology of Denosumab in Patients with Bone Metastases from Solid Tumors
    Ruixo, Juan Jose Perez
    Doshi, Sameer
    Sohn, Winnie
    Chow, Andrew
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (03): : S85 - S92
  • [25] Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany
    Ingo Diel
    Sonja Ansorge
    David Hohmann
    Christina Giannopoulou
    Daniela Niepel
    Michele Intorcia
    Supportive Care in Cancer, 2020, 28 : 5223 - 5233
  • [26] Pharmacotherapy of bone metastases in breast cancer patients
    Petrut, Bianca
    Simmons, Christine
    Broom, Reuben
    Trinkaus, Mateya
    Clemons, Mark
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (06) : 937 - 945
  • [27] Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany
    Diel, Ingo
    Ansorge, Sonja
    Hohmann, David
    Giannopoulou, Christina
    Niepel, Daniela
    Intorcia, Michele
    SUPPORTIVE CARE IN CANCER, 2020, 28 (11) : 5223 - 5233
  • [28] An Italian survey on the use of denosumab for the management of skeletal-related events in patients with bone metastases
    Berardi, R.
    Berruti, A.
    Brogelli, L.
    Zucali, P. A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (13) : 4659 - 4665
  • [29] Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases
    Udagawa, Hibiki
    Niho, Seiji
    Kirita, Keisuke
    Umemura, Shigeki
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Goto, Koichi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (06) : 1075 - 1082
  • [30] Effects of Denosumab, Alendronate, or Denosumab Following Alendronate on Bone Turnover, Calcium Homeostasis, Bone Mass and Bone Strength in Ovariectomized Cynomolgus Monkeys
    Kostenuik, Paul J.
    Smith, Susan Y.
    Samadfam, Rana
    Jolette, Jacquelin
    Zhou, Lei
    Ominsky, Michael S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2015, 30 (04) : 657 - 669
12345